We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
301
APA Corp
APA
$12.8B
$1.97M 0.05%
35,459
+6,385
+22% +$347K
CHRW icon
302
C.H. Robinson
CHRW
$22B
$1.97M 0.05%
26,518
+5,662
+27% +$414K
EBAY icon
303
eBay
EBAY
$48.6B
$1.96M 0.05%
83,666
+15,939
+24% +$385K
S
304
DELISTED
Sprint Corporation
S
$1.96M 0.05%
432,432
-285,137
-40% -$1.06M
SO icon
305
Southern Company
SO
$110B
$1.92M 0.05%
35,872
-85,545
-70% -$4.3M
ARIA
306
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.92M 0.05%
260,000
+90,000
+53% +$675K
BMO icon
307
Bank of Montreal
BMO
$125B
$1.91M 0.05%
30,294
-75,761
-71% -$4.8M
BLUE
308
DELISTED
bluebird bio
BLUE
$1.91M 0.05%
3,397
-1,119
-25% -$634K
MAC icon
309
Macerich
MAC
$7.32B
$1.89M 0.05%
+22,158
New +$1.73M
SWN
310
DELISTED
Southwestern Energy Company
SWN
$1.89M 0.05%
150,048
-156,147
-51% -$1.89M
EPZM
311
DELISTED
Epizyme, Inc
EPZM
$1.88M 0.05%
184,000
+24,000
+15% +$268K
AGEN
312
Agenus
AGEN
$249M
$1.85M 0.05%
23,320
MS icon
313
Morgan Stanley
MS
$337B
$1.85M 0.05%
71,374
+17,970
+34% +$470K
LXRX icon
314
Lexicon Pharmaceuticals
LXRX
$1.02B
$1.84M 0.05%
128,000
-25,000
-16% -$339K
PX
315
DELISTED
Praxair Inc
PX
$1.83M 0.05%
16,270
+6,497
+66% +$737K
AVXS
316
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.82M 0.05%
+48,000
New +$1.62M
DO
317
DELISTED
Diamond Offshore Drilling
DO
$1.8M 0.05%
74,049
+1,726
+2% +$41.1K
CEMP
318
DELISTED
Cempra, Inc.
CEMP
$1.8M 0.05%
109,000
-6,000
-5% -$106K
PNC icon
319
PNC Financial Services
PNC
$100B
$1.77M 0.05%
21,790
+4,842
+29% +$416K
DE icon
320
Deere & Co
DE
$170B
$1.77M 0.05%
21,840
+2,451
+13% +$201K
JCI icon
321
Johnson Controls International
JCI
$87.5B
$1.75M 0.05%
37,751
-104,275
-73% -$4.59M
STJ
322
DELISTED
St Jude Medical
STJ
$1.75M 0.05%
22,372
-50,068
-69% -$3.57M
HALO icon
323
Halozyme
HALO
$9.72B
$1.74M 0.05%
202,000
-30,000
-13% -$296K
TMUS icon
324
T-Mobile US
TMUS
$193B
$1.74M 0.05%
40,090
-38,969
-49% -$1.6M
SBAC icon
325
SBA Communications
SBAC
$18.4B
$1.73M 0.05%
16,045
+7,285
+83% +$739K

Similar funds

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.